.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
McKesson
Medtronic
Mallinckrodt
US Army
QuintilesIMS
Healthtrust
Chubb
Merck
Chinese Patent Office

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021656

« Back to Dashboard
NDA 021656 describes TRICOR, which is a drug marketed by Abbvie Inc and Abbvie and is included in three NDAs. It is available from fourteen suppliers. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the TRICOR profile page.

The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

Summary for 021656

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:7
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021656

Medical Subject Heading (MeSH) Categories for 021656

Suppliers and Packaging for NDA: 021656

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRICOR
fenofibrate
TABLET;ORAL 021656 NDA AbbVie Inc. 0074-3173 0074-3173-90 90 TABLET in 1 BOTTLE (0074-3173-90)
TRICOR
fenofibrate
TABLET;ORAL 021656 NDA AbbVie Inc. 0074-3189 0074-3189-90 90 TABLET in 1 BOTTLE (0074-3189-90)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength48MG
Approval Date:Nov 5, 2004TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Jan 9, 2018Product Flag?Substance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Sep 21, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)
Patent:► SubscribePatent Expiration:Jan 9, 2018Product Flag?Substance Flag?YDelist Request?

Expired Orange Book Patents for NDA: 021656

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
TRICOR
fenofibrate
TABLET;ORAL021656-001Nov 5, 2004► Subscribe► Subscribe
Abbvie
TRICOR
fenofibrate
TABLET;ORAL021656-002Nov 5, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Accenture
Cantor Fitzgerald
Chinese Patent Office
Baxter
US Department of Justice
UBS
Express Scripts
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot